ERAD Therapeutics Inc. — Form D
ERAD Therapeutics Inc. of CALEDON, A6, a company, filed a Form D exempt-offering notice with the SEC on 2015-11-09. The offering totals $175K, of which $84K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-11-09
- Form: D
- Accession: 0001655883-15-000001
- Industry: Biotechnology
- Exemptions: 05
- Total offering: $175K
- Amount sold: $84K
- Remaining: $91K
- Minimum investment: $20K
- Investors: 4
- Date of first sale: 2015-10-23
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-250869
Issuer
- Name: ERAD Therapeutics Inc.
- CIK: 0001655883
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2014
- Address: 6 CEDAR DRIVE, CALEDON, A6, L7K 1H6
- Phone: 416-894-4317
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Robert Alexander BENDER | Director | Ottawa, A6 |
| Craig Alexander Sibley | Director | Caledon, A6 |
| George Alexander Spitalny | Director | Yardley, PA |
| Craig Alexander Sibley | Executive Officer | Caledon, A6 |
| George Alexander Spitalny | Executive Officer | Yardley, PA |
More